Modeling & Meta-Analysis; Real-World Evidence & Data Analytics; Strategic Market Access
Principal & Executive Director
Bethesda, United States
Xin (Cindy) Gao is Asia-Pacific Regional Lead of Pharmerit International as well as a Partner of Pharmerit (Shanghai) Company Limited (傅盟医药咨询（上海）有限公司) of Pharmerit International, and is based in our Bethesda, MD office. Dr. Gao has more than 17 years of experience in health economics consulting, previous working at PPD and Abt Associates.
Her primary research interests are in the areas of evidence-based medicine/health technology assessments, risk assessment and management, and outcomes research. She is experienced in preparing and submitting pharmaceutical product assessments to health technology assessment (HTA) authorities. She has considerable experience at building market-relevant health economic models; designing and implementing prospective health economic and outcomes trial studies (e.g., developing protocol and corresponding SAP, guiding data analysis, and writing the related sections in the final study report that submitted to FDA); and conducting strategic market access projects (e.g., systematic and targeted literature reviews, HEOR compendiums and strategic plans, value decks, and communication tools such as GUI Apps). She has also worked on many real-world evidence studies from claims and EMR database analyses to chart reviews and survey studies. Her consulting assignments have focused on numerous therapeutic areas, including arthritis, infectious diseases (e.g., hepatitis B & C, HIV, pneumonia), oncology (e.g., renal, breast, colorectal, and prostate cancers), women’s health (e.g., osteoporosis, urinary incontinence), perioperative hypothermia, sexual dysfunction, and cardiovascular disease, among many others. Dr. Gao holds a B.S. in Pharmaceutical Sciences from China Pharmaceutical University and a Ph.D. in Pharmaceutical Economics and Health Policy from West Virginia University School of Pharmacy.